# Nxtcure Labs Landing Page Growth Score | YC F26 | Lazyweb

Lazyweb publishes a public search API over its indexed pages; the guide is at https://www.lazyweb.com/agent-access.

Source: https://www.lazyweb.com/yc-f26/nxtcure-labs
Source observed: 2026-10-17T09:37:31.186Z
Last checked: 2026-10-20T07:41:36.402+00:00
Indexed: 2026-10-17T13:41:09.092+00:00

---

# Nxtcure Labs Landing Page Growth Score

We provide a Growth Score report for [Nxtcure Labs](https://nxtcure.com/) in the YC F26 group. The report evaluates the landing page across Trust, Information hierarchy, CTA, Mobile web, and Value props.

## Overall score

- **Growth score:** 69/100
- **Updated:** September 20, 2026
- **Weakest category:** Trust
- **Category scores:** Trust 56, Information hierarchy 68, CTA 72, Mobile web 72, Value props 76

[Fix Trust](https://www.lazyweb.com/plans/checkout?plan=individual&source=growth_score_feature_build_fixes)

## Ranking

1. Nxtcure Labs — **69**
2. [Faro Health — 65](https://www.lazyweb.com/growth-score/site/farohealth.com)
3. [Lindus Health — 61](https://www.lazyweb.com/growth-score/site/lindushealth.com)
4. [Paradigm — 54](https://www.lazyweb.com/growth-score/site/paradigm.inc)
5. [Unlearn.AI — 40](https://www.lazyweb.com/growth-score/site/unlearn.ai)

## Score over time

The report includes a score-history chart comparing Nxtcure Labs, Lindus Health, Unlearn.AI, Faro Health, and Paradigm.

## Trust — 56/100, Fair

Trust measures proof that the product is real, competent, and safe to try.

![Nxtcure Labs trust-report capture](https://zlfyzdmohcskkucuunmk.supabase.co/storage/v1/object/public/sites/growth-score/site/nxtcure.com.jpg?v=2026-09-20T06%3A24%3A28.449%2B00%3A00)

Our trust comparison records these visible signals:

| Company | Trust read |
| --- | --- |
| Nxtcure Labs | Orchestrate · CTX-NSCLC-301 product card showing agent pipeline statuses: “2 awaiting human review · 0 silent failures” |
| Lindus Health | “82% of Lindus trials completed enrollment on or ahead of timeline,” with a footnote beginning “Measured against all 28 trials that c…” |
| Unlearn.AI | Dimmed top banner referencing a 2025 AI Innovation Awards win for clinical trial design, obscured behind the webinar modal |
| Faro Health | Hero screenshot of the Clinical Trial Optimization Report UI with executive-summary and cost-savings metrics |
| Paradigm | No visible trust signal identified |

**Trust ranking:** Lindus Health 62; Nxtcure Labs 56; Faro Health 48; Paradigm 42; Unlearn.AI 32.

[Build proof section](https://www.lazyweb.com/backlog?site=nxtcure.com#opt-trust-signals) to choose proof signals and receive copy and placement for a stronger trust section.

## Information hierarchy — 68/100, Fair

![Information hierarchy annotations on the desktop capture](https://zlfyzdmohcskkucuunmk.supabase.co/storage/v1/object/public/sites/growth-score/site/nxtcure.com.jpg?v=2026-09-20T06%3A24%3A28.449%2B00%3A00)

The report identifies four issues:

1. **Eight-item nav row:** Eight equal-weight links, from Human checkpoint through Advisors, create exit paths before visitors reach the hero promise.
2. **Rotating headline keyword:** A typewriter effect swaps the core promise, including “site activation” and “tumor analysis,” so the value proposition is not stable at a glance.
3. **Hero paragraph block:** A dense six-line paragraph encourages reading rather than scanning; the report recommends splitting it into shorter beats.
4. **Duplicate Book a demo:** The navigation “Book a demo” pill has equal visual weight to the hero CTA and splits the scan path.

[View layout plan](https://www.lazyweb.com/backlog?site=nxtcure.com#opt-information-hierarchy)

## CTA — 72/100, Fair

![Nxtcure Labs CTA report capture](https://zlfyzdmohcskkucuunmk.supabase.co/storage/v1/object/public/sites/growth-score/site/nxtcure.com.jpg?v=2026-09-20T06%3A24%3A28.449%2B00%3A00)

The analyzed primary CTA is **“Book a demo.”** Identified problems:

- The click feels like a sales meeting.
- There is no value framing beyond “demo.”
- There is no low-commitment alternative CTA.

**CTA ranking:** Nxtcure Labs 72; Faro Health 62; Lindus Health 55; Unlearn.AI 52; Paradigm 48.

[Rewrite this CTA](https://www.lazyweb.com/backlog?site=nxtcure.com#opt-cta-writing) to generate primary and secondary CTA options grounded in Nxtcure Labs’s offer and visitor objections.

## Mobile web — 72/100, Fair

![Mobile web annotations on the mobile capture](https://zlfyzdmohcskkucuunmk.supabase.co/storage/v1/object/public/sites/growth-score/site/nxtcure.com-mobile.jpg?v=2026-09-20T06%3A24%3A28.449%2B00%3A00)

The report identifies two mobile issues:

1. **Hero body paragraph:** Eleven lines of desktop-length copy fill the fold and push the “Book a demo” CTA below the first viewport.
2. **Animated headline cursor:** An oversized block cursor truncates “tumor analys” mid-word, making the value statement appear broken.

[View mobile fixes](https://www.lazyweb.com/backlog?site=nxtcure.com#opt-mobile-web)

## Value props — 76/100, Fair

The report describes Nxtcure Labs’s headline as:

> “Agents do the routine work of site activation.”

The accompanying copy says Nxtcure Labs is changing medicine by running clinical trials end to end; people make the calls; Galen is a full-stack AI-driven CRO; thirteen purpose-built agents run a study end to end in lifecycle order; and every action with clinical, safety, regulatory, or financial consequence stops in one review queue until a qualified human approves it.

**Working:**

- The rotating headline names real trial tasks.
- “Thirteen agents” and “one review queue” are concrete.
- The hero card demonstrates a live Phase 3 study.

**Could improve:**

- No outcome metric shows time or cost saved.
- “Changing the future of medicine” is filler.
- The subhead is long and buries “one review queue.”

**Value-proposition ranking:** Nxtcure Labs 76; Lindus Health 62; Faro Health 62; Paradigm 52; Unlearn.AI 38.

## Competitors

The report infers these competitors from product, audience, and value proposition:

1. Nxtcure Labs — **69**
2. [Faro Health](https://www.lazyweb.com/growth-score/site/farohealth.com) — **65** — farohealth.com
3. [Lindus Health](https://www.lazyweb.com/growth-score/site/lindushealth.com) — **61** — lindushealth.com
4. [Paradigm](https://www.lazyweb.com/growth-score/site/paradigm.inc) — **54** — paradigm.inc
5. [Unlearn.AI](https://www.lazyweb.com/growth-score/site/unlearn.ai) — **40** — unlearn.ai

---

[Read this page’s summary](https://www.lazyweb.com/api/public/v1/page-tldr?url=https%3A%2F%2Fwww.lazyweb.com%2Fyc-f26%2Fnxtcure-labs&trace=t_bc7e1c4e5b07)

## Ask a follow-up about this page

Need a more specific answer? Ask the exact question you have. It returns a fresh, cited answer from Lazyweb’s knowledge base. No account or API key required.

Open this URL with your own question, URL-encoded. Only q is required. No account or setup.

`GET https://www.lazyweb.com/agent/faq?q={question}&trace=t_bc7e1c4e5b07`

[Tool guide and examples](https://www.lazyweb.com/agent-access) · [OpenAPI](https://www.lazyweb.com/api/public/v1/openapi.json) · [Page TLDR form](https://www.lazyweb.com/agent-tools/page-tldr?url=https%3A%2F%2Fwww.lazyweb.com%2Fyc-f26%2Fnxtcure-labs). Opening a form does not execute a tool.